The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2015

Filed:

Aug. 21, 2009
Applicants:

Yusuke Nakamura, Tokyo, JP;

Toyomasa Katagiri, Tokyo, JP;

Akira Togashi, Kanagawa, JP;

Inventors:

Yusuke Nakamura, Tokyo, JP;

Toyomasa Katagiri, Tokyo, JP;

Akira Togashi, Kanagawa, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); A61K 38/00 (2006.01); C07K 7/00 (2006.01); C07K 14/00 (2006.01); C07K 14/82 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/82 (2013.01); C12N 15/113 (2013.01); G01N 33/5011 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01); C07K 2319/10 (2013.01); C12N 2310/14 (2013.01);
Abstract

The present invention provides therapeutic agents and methods for treating cancer using the polypeptides composed of an amino acid sequence which includes a polypeptide fragment of DEPDC1. The polypeptides of the present invention can be introduced into cancer cells by modifying the polypeptides with transfection agents such as poly-arginine. Furthermore, the present invention provides methods of screening for therapeutic agents or compounds useful in inhibition of the DEPDC1/ZN-F224 complex formation or the treatment of cancer. The present invention also provides siRNAs targeting the ZNF224 gene, which are suggested to be useful in the treatment of bladder cancer.


Find Patent Forward Citations

Loading…